LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Search

AstraZeneca PLC ADR

Fermé

77.99 -0.4

Résumé

Variation du prix de l'action

24h

Actuel

Min

77.84

Max

78.38

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+17.9 upside

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

AstraZeneca PLC ADR Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 sept. 2024, 09:29 UTC

Principaux Mouvements du Marché

AstraZeneca Shares Slump After Cancer Drug Misses Key Target

25 juil. 2024, 09:17 UTC

Résultats

AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update

25 juil. 2024, 06:48 UTC

Résultats

AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations

12 sept. 2024, 17:01 UTC

Actualités

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- Update

12 sept. 2024, 11:00 UTC

Actualités

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ

10 sept. 2024, 13:08 UTC

Market Talk

AstraZeneca's Lung Cancer Drug Candidate Disappoints, Lowering Probability of FDA Approval -- Market Talk

9 sept. 2024, 07:56 UTC

Market Talk

Big Pharma's Stability in Return on R&D Investment Is Encouraging -- Market Talk

5 sept. 2024, 13:00 UTC

Actualités

China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ

29 juil. 2024, 10:30 UTC

Actualités

Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ

25 juil. 2024, 13:20 UTC

Résultats

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

25 juil. 2024, 09:21 UTC

Market Talk
Résultats

AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk

25 juil. 2024, 07:05 UTC

Market Talk
Résultats

AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk

25 juil. 2024, 06:06 UTC

Résultats

AstraZeneca Increased Interim Dividend by 7c to $1.00

25 juil. 2024, 06:04 UTC

Résultats

AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range

25 juil. 2024, 06:04 UTC

Résultats

AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range

25 juil. 2024, 06:04 UTC

Résultats

AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25 juil. 2024, 06:04 UTC

Résultats

AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25 juil. 2024, 06:03 UTC

Résultats

AstraZeneca Raises 2024 View

25 juil. 2024, 06:02 UTC

Résultats

AstraZeneca 2Q Revenue Consensus Was $12.7B

25 juil. 2024, 06:02 UTC

Résultats

AstraZeneca 2Q Core EPS Consensus Was $1.95

25 juil. 2024, 06:00 UTC

Résultats

AstraZeneca PLC 2Q Adj EPS $1.98

25 juil. 2024, 06:00 UTC

Résultats

AstraZeneca PLC 2Q Pretax Pft $2.4B

25 juil. 2024, 06:00 UTC

Résultats

AstraZeneca PLC 2Q Rev $12.94B

25 juil. 2024, 06:00 UTC

Résultats

AstraZeneca PLC 2Q Oper Pft $2.75B

25 juil. 2024, 06:00 UTC

Résultats

AstraZeneca PLC 2Q Net Pft $1.93B

25 juil. 2024, 06:00 UTC

Résultats

AstraZeneca PLC 2Q EPS $1.24

15 juil. 2024, 06:04 UTC

Acquisitions, Fusions, Rachats

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 juil. 2024, 06:04 UTC

Acquisitions, Fusions, Rachats

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 juil. 2024, 06:02 UTC

Acquisitions, Fusions, Rachats

AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing

15 juil. 2024, 06:02 UTC

Acquisitions, Fusions, Rachats

AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B

Comparaison

Variation de prix

AstraZeneca PLC ADR prévision

Objectif de Prix

By TipRanks

17.9% hausse

Prévisions sur 12 Mois

Moyen 92.33 USD  17.9%

Haut 99 USD

Bas 86 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

7 ratings

6

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

77.47 / 79.01Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

No Evidence

Éléments financiers

$